Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. (SHA:900904)

China · Delayed Price · Currency is CNY · Price in USD

0.4400

-0.0020 (-0.45%)

At close: Sep 30, 2026

Market Cap	4.09B +31.2%
Revenue (ttm)	1.84B -3.1%
Net Income	27.40M -58.7%
EPS	0.05 -58.3%
Shares Out	n/a
PE Ratio	149.16
Forward PE	n/a
Dividend	0.07 (2.38%)
Ex-Dividend Date	Jun 17, 2026

Volume	156,651
Open	0.4440
Previous Close	0.4420
Day's Range	0.4380 - 0.4450
52-Week Range	0.4030 - 0.5380
Beta	0.56
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 31, 2026

About SHA:900904

Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sales of pharmaceuticals in China and internationally. The company offers patented anti-tumor drugs; topical antibacterial series; products for hypertension, hyperlipidemia, and hyperglycemia chronic diseases; classic Chinese medicine cough relief series; classic tonic product series; Miao medicine for strengthening muscles and bones series; and magical doll medicine series. It also provides tooth... [Read more]

Industry Drug Manufacturers - General

Sector Healthcare

Founded 1992

Employees 1,196

Stock Exchange Shanghai Stock Exchange

Ticker Symbol 900904

Financial Performance

In 2025, SHA:900904's revenue was 1.95 billion, a decrease of -4.71% compared to the previous year's 2.05 billion. Earnings were 38.24 million, a decrease of -46.43%.

Financial Statements